| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |